Glycolipids are conjugates of a lipid and a carbohydrate, typically an oligosaccharide. In mammals, most glycolipids belong to the glycosphingolipid class, in which the lipid moiety is a ceramide—comprising a sphingosine backbone linked to a fatty acid.
Glycosphingolipids are further classified based on their carbohydrate composition:
- Gangliosides– contain one or more sialic acid residues.
- Sulfatides– feature sulfated monosaccharides, usually galactose.
- Globosides– possess neutral oligosaccharides (e.g., Gal, Glc, GalNAc).
- Cerebrosides– contain a single monosaccharide, such as glucose or galactose.
Glycolipids are essential components of all cell membranes, typically comprising 2–10% of total membrane lipids, and are particularly enriched in the outer leaflet of the plasma membrane, where they contribute to cell recognition, signaling, and membrane microdomain formation.
Analysis can be performed on the full glycolipid, which captures the heterogeneity of the fatty acid residue or on the glycan moiety only after enzymatic cleavage, e.g, with a ceramidase. A full glycolipid profile that includes variability both in the lipid and glycan moieties can be provided by UPLC-MS.
MALDI-TOF MS profiling of released glycans from glycolipids
After enzymatic release, the glycans can be permethylated to improve ionization efficiency and to stabilize sialic acid residues before analysis by MALDI-TOF MS. It is possible to achieve absolute quantification by spiking the sample with our stable isotope-labeled (SIL) glycan standards (CarboQuant).
MALDI-TOF analysis of ceramidase-released and permethylated glycosphingolipid glycans from tissue.
UHPLC-FLD-MS profiling of released glycans from glycolipids
It allows the identification of the glycans present in a sample based on their mass and retention time. This method employs ultra-high-performance liquid chromatography (UHPLC) with hydrophilic interactions (HILIC) for increased sensitivity and selectivity, allowing the separation of most isobaric isomers.
Glycans can be derivatized with a fluorophore like 2-AB, 2-AA, RapiFluor, or procainamide, which permits the relative quantification of all glycans in the mixture by fluorimetry. The fragmentation of glycans by MS/MS can create diagnostic fragment ions that help elucidate glycan structure and assign isomers.
How we work for Glycolipid Profiling
Our workflow ensures a clear, straightforward, and transparent process for sample glycoanalysis
Sample
Let us know which type of sample (purified glycolipids, cells, tissue, etc.) you want to analyze, and we will apply the most convenient sample preparation protocol.
Glycosphingolipids Extraction
By the Folch method.
Glycan release
Using ceramidases.
Sample purification and labelling
We enrich, purify, and label the samples accordingly to obtain the best signals.
Mass spectrometry analysis
The latest technology and instruments are used to ensure the data quality.
Data processing
Our experts analyze and interpret the data to transform it into actionable information.
Report
A publication-type report that includes the Materials & Methods, data interpretation, and potential further analysis.
Purposes and applications for Glycolipid Profiling
Glycan profiling of complex samples containing glycolipids (cerebrosides, globosides, gangliosides) serves several purposes and applications:
Neuroscience & Development
Profiling gangliosides in neurodevelopment, plasticity, and neurodegeneration
Biomarkers & Diagnostics
Disease-specific glycolipid signatures act as sensitive biomarkers. We can detect and monitor cancers and lysosomal storage disorders (e.g., Gaucher, Fabry, Tay‑Sachs), improving cancer diagnostics, neurological disease monitoring, and personalized medicine approaches
Immunology & Inflammatory Diseases
Changes in glycolipid composition modulate immune cell activation and inflammation; profiling enables diagnostic markers and the development of glycan-based immunomodulators
Studying roles in membrane organization, receptor clustering, and immune modulation provides key information about signaling
Oncology
Glycolipid profiling uncovers tumor-associated gangliosides and altered glycosphingolipids that drive cell signaling and metastasis, supporting biomarker discovery and the design of therapeutic vaccines
Infectious Diseases
Many pathogens recognize host glycolipids as receptors, e.g., GM1 for cholera toxin
Profiling these interactions informs antiviral targets, antibacterial drug development, and vaccine design
Microbiome
Host glycolipids shape microbial colonization and metabolism in the gut; their analysis supports probiotic design and microbiota-targeted interventions
Other Fields
- Veterinary medicine: glycolipid biomarkers contribute to disease surveillance and vaccine development in livestock and companion animals
- Plants and Agriculture: glycolipid analysis reveals roles in membrane stability and stress adaptation
- Nutraceuticals and cosmetics: it drives the identification of bioactive lipids for health and skin applications
- Human Milk Oligosaccharides (HMOs): glycolipid mimetics support infant immune development
Therapeutic discovery and monitoring
Validating targets (e.g., GD2, Globo H), monitoring enzyme or substrate reduction therapies, and aiding vaccine/nanomedicine design
